Latest Hematology & Oncology News
Achieving PSA <0.2 ng/mL Improves Survival in Metastatic Castration-Sensitive Prostate Cancer
posted August 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
Study IDs Gaps in Hereditary Breast Cancer Risk Assessment Before Gender-Affirming Mastectomy
posted August 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
Cancer-Attributable Costs High for Seniors, Vary With Cancer Phase, Type, Race
posted August 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer
posted August 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer 
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported 
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL Related Articles
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Personalized Support Boosts Families" Genetic Testing for Hereditary Cancers 
Pre-Prostate Biopsy MRI Use Increased From 2017 to 2026 
Exercise Intervention Linked to Improved Attention, Memory in Breast Cancer Hematology & Oncology Conference Highlights
Hematology & Oncology Monthly Briefings
Hematology & Oncology Conference News
Stay Connected
